Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Hess · SciRah

Researcher profile · Semantic Scholar

K. Hess

Share profile

K. Hess — researcher profile on SciRah

h-index: 91
Works: 519
Citations: 55K

Most-cited papers

The association of BMI and outcomes in metastatic melanoma: A retrospective, multicohort analysis of patients treated with targeted therapy, immunotherapy, or chemotherapy
J. McQuade, C. Daniel, K. Hess, Carmen Mak +42 more
2018The Lancet Oncology582 citations Open access
Semantic Scholar
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
J. Welsh, H. Menon, Dawei Chen, V. Verma +13 more
2020Journal for ImmunoTherapy of Cancer263 citations Open access
Semantic Scholar
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant.
J. Litton, M. Scoggins, K. Hess, B. Adrada +15 more
2020Journal of Clinical Oncology174 citations Open access
Semantic Scholar
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses
J. Welsh, Chad Tang, P. D. de Groot, A. Naing +27 more
2019Cancer immunology research129 citations Open access
Semantic Scholar
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
M. Habra, B. Stephen, M. Campbell, K. Hess +15 more
2019Journal of Immunotherapy for Cancer127 citations Open access
Semantic Scholar
Phase 2 study of pembrolizumab in patients with advanced rare cancers
A. Naing, F. Meric-Bernstam, B. Stephen, D. Karp +36 more
2020Journal for ImmunoTherapy of Cancer122 citations Open access
Semantic Scholar
Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials
J. Atkins, G. George, K. Hess, Kathrina L. Marcelo-Lewis +5 more
2020British Journal of Cancer110 citations Open access
Semantic Scholar
Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC
J. Welsh, J. Heymach, Chun-Xiao Guo, H. Menon +20 more
2020Journal of Thoracic Oncology94 citations Open access
Semantic Scholar
Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.
J. Welsh, J. Heymach, Dawei Chen, V. Verma +15 more
2020Journal of Thoracic Oncology82 citations Open access
Semantic Scholar
Cell-Free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer
Seyed Pairawan, K. Hess, F. Janku, Nora S. Sanchez +12 more
2019Clinical Cancer Research69 citations Open access
Semantic Scholar
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
C. Liedtke, C. Mazouni, K. Hess, F. André +9 more
2023Journal of Clinical Oncology62 citations
Semantic Scholar
Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer.
Dawei Chen, H. Menon, V. Verma, S. Seyedin +16 more
2019JAMA Oncology60 citations Open access
Semantic Scholar
Targeting ERBB2 (HER2) Amplification Identified by Next-Generation Sequencing in Patients With Advanced or Metastatic Solid Tumors Beyond Conventional Indications
E. I. Ileana Dumbrava, K. Balaji, K. Raghav, K. Hess +16 more
2019JCO Precision Oncology55 citations Open access
Semantic Scholar
Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non–small cell lung cancer after concurrent chemoradiation
Yang Liu, Jia Fan, Ting Xu, Navid Ahmadinejad +8 more
2020Science Advances48 citations Open access
Semantic Scholar
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
A. Hegde, Alexander Y. Andreev-Drakhlin, J. Roszik, Le Huang +18 more
2020ESMO Open48 citations Open access
Semantic Scholar
Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer.
Yu-Yi Chu, C. Yam, Mei-Kuang Chen, Li-Chuan Chan +15 more
2020American Journal of Cancer Research43 citations
Semantic Scholar
Alpha particle Radium 223 dichloride in high-risk osteosarcoma: a phase I dose escalation trial
V. Subbiah, P. Anderson, K. Kairemo, K. Hess +13 more
2019Clinical Cancer Research43 citations Open access
Semantic Scholar
Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas
V. Levin, S. Ictech, K. Hess
2018CNS Oncology40 citations Open access
Semantic Scholar
Modified FOLFIRINOX in Pancreatic Cancer Patients Age 75 or Older
J. Mizrahi, J. Rogers, K. Hess, R. Wolff +8 more
2020Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]37 citations Open access
Semantic Scholar
Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center
E. Asare, Angelica M. Silva-Figueroa, K. Hess, N. Busaidy +5 more
2019Annals of Surgical Oncology36 citations
Semantic Scholar
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study
C. Yam, F. Esteva, M. Patel, A. Raghavendra +11 more
2019Investigational new drugs31 citations
Semantic Scholar
Biological Validation of RNA Sequencing Data from Formalin-Fixed Paraffin-Embedded Primary Melanomas
Lawrence N. Kwong, M. P. de Macedo, L. Haydu, Aron Y. Joon +9 more
2018JCO Precision Oncology30 citations Open access
Semantic Scholar
High Flow Nasal Cannula Therapy for Exertional Dyspnea in Cancer Patients: A Pilot Randomized Clinical Trial.
D. Hui, D. Mahler, Liliana Larsson, Jimin Wu +10 more
2020The Oncologist26 citations Open access
Semantic Scholar
Minimally Invasive Cordotomy for Refractory Cancer Pain: A Randomized Controlled Trial.
A. Viswanathan, A. Vedantam, K. Hess, J. Ochoa +5 more
2019The Oncologist26 citations Open access
Semantic Scholar
Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer
A. Bagley, M. Anscher, Seungtaek L. Choi, S. Frank +11 more
2020JAMA Network Open25 citations Open access
Semantic Scholar
High risk breast lesions identified on MRI-guided vacuum-assisted needle biopsy: outcome of surgical excision and imaging follow-up.
Megan E Speer, Monica L. Huang, B. Dogan, B. Adrada +5 more
2018British Journal of Radiology25 citations Open access
Semantic Scholar
Sleep disturbance in patients with cancer: a feasibility study of multimodal therapy
S. Yennurajalingam, C. Carmack, D. Balachandran, C. Eng +10 more
2020BMJ Supportive & Palliative Care22 citations
Semantic Scholar
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies
Yu-Dong Wang, F. Janku, S. Piha-Paul, K. Hess +12 more
2020Scientific Reports21 citations Open access
Semantic Scholar
Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy
Anna Weiss, S. Bashour, K. Hess, A. Thompson +1 more
2018Breast Cancer Research21 citations Open access
Semantic Scholar
Retrospective Review of a Mobile Mammography Screening Program in an Underserved Population within a Large Metropolitan Area
D. Spak, Lewis E. Foxhall, A. Rieber, K. Hess +2 more
2020Academic Radiology19 citations Open access
Semantic Scholar
Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory
T. Mendoza, A. Sheshadri, M. Altan, K. Hess +21 more
2020Journal for ImmunoTherapy of Cancer18 citations Open access
Semantic Scholar
Imaging of Intracystic Papillary Carcinoma.
Megan E Speer, B. Adrada, Elsa M. Arribas, K. Hess +2 more
2019Current problems in diagnostic radiology18 citations
Semantic Scholar
Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational Study
G. George, Eucharia C Iwuanyanwu, A. Buford, S. Piha-Paul +10 more
2019Journal of Medical Internet Research18 citations Open access
Semantic Scholar
Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and Observation
Stephen R. Grant, X. Lei, K. Hess, Grace L. Smith +8 more
2020Advances in Radiation Oncology16 citations Open access
Semantic Scholar
Imaging Follow-up Versus Surgical Excision for Radial Scars Identified on Tomosynthesis-Guided Core Needle Biopsy.
Sarah Martaindale, Toma S. Omofoye, Davis C. Teichgraeber, K. Hess +1 more
2020Academic Radiology16 citations
Semantic Scholar
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)
Abeer H. Abdelhafez, Benjamin C. Musall, B. Adrada, K. Hess +23 more
2020Breast Cancer Research and Treatment16 citations Open access
Semantic Scholar
Immediate Migration of Biopsy Clip Markers After Upright Digital Breast Tomosynthesis-Guided Vacuum-Assisted Core Biopsy.
Davis C. Teichgraeber, Sarah Martaindale, Toma S. Omofoye, K. Hess +2 more
2020Academic Radiology15 citations
Semantic Scholar
Imaging features of triple negative breast cancer and the effect of BRCA mutations
N. Karbasian, Sahand Sohrabi, Toma S. Omofoye, H. Le-Petross +5 more
2020Current problems in diagnostic radiology15 citations Open access
Semantic Scholar
Abstract CT020: Phase I dose escalation of olaparib (PARP inhibitor) and selumetinib (MEK Inhibitor) combination in solid tumors with Ras pathway alterations
K. Kurnit, F. Meric-Bernstam, K. Hess, R. Coleman +13 more
2019Clinical Trials15 citations
Semantic Scholar
Erratum: Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions
Chen Fu, D. Gombos, Jared Lee, G. George +3 more
2019OncoTarget15 citations Open access
Semantic Scholar
Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data
Chad Tang, X. Lei, Grace L. Smith, Hubert Y. Pan +9 more
2020Practical Radiation Oncology14 citations Open access
Semantic Scholar
Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1)
L. Báez-Vallecillo, A. Raghavendra, K. Hess, C. Barcenas +4 more
2019Breast Cancer Research and Treatment14 citations
Semantic Scholar
Multi-kinase RET inhibitor vandetanib combined with mTOR inhibitor everolimus in patients with RET rearranged non-small cell lung cancer.
V. Subbiah, T. Cascone, K. Hess, I. Subbiah +15 more
201814 citations
Semantic Scholar
Randomized phase I/II trial of pembrolizumab with and without radiotherapy for metastatic non-small cell lung cancer.
J. Welsh, H. Menon, Chad Tang, V. Verma +9 more
2019Journal of Clinical Oncology13 citations
Semantic Scholar
Neoadjuvant Pertuzumab‐containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER‐2/neu‐positive Breast Cancer: A Retrospective, Single Institution Experience
R. Murthy, A. Raghavendra, K. Hess, T. Fujii +12 more
2018Clinical Breast Cancer12 citations
Semantic Scholar
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience
N. Majd, M. Mastall, Heather Y. Lin, S. Dibaj +22 more
2021Neuro-Oncology Advances11 citations Open access
Semantic Scholar
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
T. Cascone, R. Sacks, I. Subbiah, N. Drobnitzky +16 more
2021ESMO Open11 citations Open access
Semantic Scholar
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience
Timothy A. Gregory, Maximilian Mastall, Heather Y. Lin, K. Hess +22 more
2023Neuro-Oncology Advances10 citations Open access
Semantic Scholar
Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors
C. Tapia, P. Aung, S. Roy-Chowdhuri, Ming-Xuan Xu +12 more
2020Journal for ImmunoTherapy of Cancer10 citations Open access
Semantic Scholar
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
T. Iwase, K. Harano, H. Masuda, K. Kida +10 more
2020BMC Cancer9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Hong×14
Invite
D. Hong — researcher profile on SciRah
V. Subbiah×12
Invite
V. Subbiah — researcher profile on SciRah
F. Meric-Bernstam×10
Invite
F. Meric-Bernstam — researcher profile on SciRah
Chad Tang×8
Invite
Chad Tang — researcher profile on SciRah

×8

Invite

Q. Nguyen — researcher profile on SciRah

Invite

A. Naing — researcher profile on SciRah

Invite

G. Simon — researcher profile on SciRah

Invite

J. Heymach — researcher profile on SciRah

Invite

G. Whitman — researcher profile on SciRah

Invite

S. Pant — researcher profile on SciRah

Invite

S. Fu — researcher profile on SciRah

Invite

J. Welsh — researcher profile on SciRah